Skip to main content
TipRanks
Go Ultimate75% OFF

Nicholas Saccomano Insider Profile

11 Followers

Nicholas Saccomano, President & CEO, Director at OnKure Therapeutics, holds 11.16K shares in OnKure Therapeutics (Ticker: OKUR), holds 0.00 shares in Array Biopharma (Ticker: ~ARRY), holds 150.19K shares in Array Technologies (Ticker: ARRY).

Nicholas Saccomano's Trading History

OKUR
OnKure Therapeutics
Sep 23, 2026President & CEO, DirectorUninformative Sell258.39$29.35K
~ARRY
Array Biopharma
Jul 30, 2019―Uninformative Sell7.21M$0.00
ARRY
Array Technologies
Apr 03, 2019CSOUninformative Buy189.47K$726.92K

You May Also Like

Nicholas Saccomano insider profile FAQ

What stocks does Nicholas Saccomano hold?
Nicholas Saccomano holds: OKUR, ~ARRY, ARRY stocks.
What was Nicholas Saccomano’s latest transaction?
Nicholas Saccomano’s latest transaction was an Uninformative Sell of $258.39.
What is Nicholas Saccomano's role in OnKure Therapeutics?
Nicholas Saccomano's role in OnKure Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.